Warning letter
Martin Avenue Pharmacy, Inc.: warning letter of Mar 18, 2015
FDA warning letter 447940 · Chicago District Office
Key facts
| Reference number | 447940 |
|---|---|
| Company | Martin Avenue Pharmacy, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Mar 18, 2015 |
| Posted date | Mar 18, 2015 |
| Issuing office | Chicago District Office |
| Product type | Drugs |
| CFR sections cited | 211.166(a), 201.115, 210, 211, 211.28(a), 211.42(c), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.67(a), 211.94(c), 211.113(b), 211.167(a) |
| Inspection city | Naperville |
| Inspection ZIP | 60540 |
| Inspection start date | Jun 30, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: